Adenocarcinoma News and Research

RSS

Adenocarcinoma is cancer that begins in cells that line certain internal organs and that have gland-like (secretory) properties.

Researchers shows how ΔNp63 protein contributes to lung cancer development

Lung cancer is the second most common cancer in the U.S. and the No. 1 cause of cancer related death. Despite considerable progress in treatment options, most lung cancer patients have extremely poor outcomes with an average five-year survival rate of 21.7%.

12 Feb 2022

Ketogenic diet could enhance the efficacy of chemotherapy for pancreatic cancer, study shows

A Ludwig Cancer Research preclinical study has demonstrated that a common weight-loss diet could enhance the efficacy of chemotherapy for pancreatic cancer.

12 Feb 2022

Novel diagnostic platform offers hope for early detection of cancer in patients with Barrett’s esophagus

On a mission to increase early detection of esophageal cancer, University of Colorado (CU) Cancer Center member Sachin Wani, MD, is leading a study to see if a novel diagnostic platform can help endoscopists better identify the disease in patients with a condition called Barrett's esophagus.

8 Feb 2022

Roswell Park scientists identify a potential new treatment target for pancreatic cancer

Scientists at Roswell Park Comprehensive Cancer Center have identified a potential new target for the treatment of pancreatic cancer.

3 Feb 2022

Trastuzumab combined with trimodality treatment for HER2-overexpressing esophageal cancer found to be ineffective

The NRG Oncology clinical trial NRG-RTOG 1010, studying the addition of the drug trastuzumab to chemoradiation and surgery, did not reach its primary goal of improving disease-free survival (DFS) rates for patients with HER2 overexpressing esophageal adenocarcinoma.

22 Jan 2022

Chinese scientists reveal key role of lysosome cell death regulator in lung tumor survival

Chinese scientists recently reported the key role of histone acetylation-regulated long noncoding RNA termed as lysosome cell death regulator (LCDR) in tumor survival, providing a potential diagnostic and therapeutic target for lung cancer.

18 Jan 2022

UCLA study provides new insights into molecular 'crosstalk' in pancreas cancer cells

Research led by scientists at the Jonsson Comprehensive Cancer Center (JCCC) at UCLA provides new insights into molecular "crosstalk" in pancreas cancer cells, identifying vulnerabilities that could provide a target for therapeutic drugs already being studied in several cancers.

12 Jan 2022

Researchers investigate SARS-CoV-2 specific inflammatory response

New research can confirm that while some of the response from monocytes to SARS-CoV-2 is generic to virus infection, most of it SARS-CoV-2 specific, especially proinflammatory responses.

7 Jan 2022

Salk researchers win $250,000 award to study cellular, molecular drivers of pancreatic cancer

Professor Ronald Evans and Assistant Professor Dannielle Engle have been granted a 2021 ASPIRE (Accelerating Scientific Platforms and Innovative Research) award to study the cellular and molecular drivers of pancreatic cancer, one of the deadliest cancers with few effective treatment options.

18 Dec 2021

Adenocarcinoma News and Research

Further Reading

Researchers shows how ΔNp63 protein contributes to lung cancer development

Ketogenic diet could enhance the efficacy of chemotherapy for pancreatic cancer, study shows

Novel diagnostic platform offers hope for early detection of cancer in patients with Barrett’s esophagus

Roswell Park scientists identify a potential new treatment target for pancreatic cancer

Trastuzumab combined with trimodality treatment for HER2-overexpressing esophageal cancer found to be ineffective

Chinese scientists reveal key role of lysosome cell death regulator in lung tumor survival

UCLA study provides new insights into molecular 'crosstalk' in pancreas cancer cells

Researchers investigate SARS-CoV-2 specific inflammatory response

Salk researchers win $250,000 award to study cellular, molecular drivers of pancreatic cancer

Advancing our understanding of T cells to improve cancer therapies

Researchers identify new drug that makes pancreatic cancer cells more vulnerable to chemotherapy

Scientists link increased air pollution to an uptick in cases of lung cancer

Scientists use the synchrotron to better understand structure of cancer cells

Exosomes involved in the progression of breast cancer in patients with obesity, diabetes

Other molecules may have greater potential as cancer therapies than gold complex auranofin

Olympus announces first results of its AI-based pathology diagnostic tool for gastric cancer

Researchers identify new symptoms associated with pancreatic cancer

Oral SARS-CoV-2 Mpro inhibitor for therapeutic use

Deadly parasite could potentially be used to treat various types of cancers

Scientists discover key component of cellular malfunction that contributes to growth of tumors

Lab Matters host Harriet Gould on building a more connected lab community

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

Latest News